HK Stock Market Move | Film and television stocks strengthened in the early trading session, with the summer box office continuing to rise. The word-of-mouth promotion of top films has driven the market demand for movie-watching to rebound.
In the morning session, film and television stocks were strong. As of the time of writing, Lemon Film and Television (09857) rose 33.03% to 5.8 Hong Kong dollars; Big Bar Entertainment (01060) rose 8.94% to 1.34 Hong Kong dollars; Maoyan Entertainment (01896) rose 6.05% to 8.24 Hong Kong dollars; IMAX CHINA (01970) rose 1.2% to 8.4 Hong Kong dollars.
The film and television stocks strengthened in the morning session. As of press time, Lemon Film and Television (09857) rose by 33.03% to 5.8 Hong Kong dollars; DAMAI ENT (01060) increased by 8.94% to 1.34 Hong Kong dollars; MAOYAN ENT (01896) rose by 6.05% to 8.24 Hong Kong dollars; IMAX CHINA (01970) rose by 1.2% to 8.4 Hong Kong dollars.
In terms of news, according to data from online platforms, as of 4:00 am on August 18, the total box office revenue for the 2025 summer season movies (including pre-sales) has reached 9.56 billion yuan, with the possibility of surpassing the 10 billion yuan mark on August 18; the total number of moviegoers has exceeded 260 million, a significant increase compared to the same period last year. In addition, the latest statistics from Maoyan Professional Edition show that the cumulative box office revenue of the domestic animated film "Wangwang Mountain Little Monster" has exceeded 1.0026 billion yuan. Zhongjin pointed out that the total box office revenue in July including service fees decreased by 24.3%, but showed a marginal recovery trend in August. The bank believes that the decline in box office revenue is mainly due to the delayed release schedule of the head films during the summer season. With the word-of-mouth fermentation of "The Nanjing Studio" and "Wangwang Mountain Little Monster," the demand for moviegoing in August has shown some signs of recovery. It is recommended to pay attention to the performance of key films at the box office and the profit elasticity brought by the commercial development of IP derivatives.
It is worth mentioning that at the beginning of 2025, the General Office of the State Council issued a notice on "Several Economic Policies to Promote High-Quality Development of Culture," emphasizing the promotion of high-quality creation in the cultural field, especially in key content creation such as film and television, animation, etc. Huaxi stated that if the policy orientation improves as expected, the film and television sector is at a turning point in 2022 when the game version numbers were released. With marginal policy improvements, the industry's business model is expected to gradually improve, high-quality long drama projects may be accelerated, and the supply of major industry dramas may gradually recover, thus accelerating destocking and accelerating the turnover of new business cash flow.
Related Articles

HK Stock Market Move | Hansoh Pharma (03692) surged nearly 6% after its performance report. Net profit in the first half of the year increased by 15% year-on-year, with innovative drug revenue accounting for over 80%.

A-share market opening express | A-shares continue to rebound! The ChiNext Index rises over 1%, and pharmaceutical stocks are collectively strong.

HK Stock Market Move | ONEWO (02602) surged more than 13% with a 3.88% year-on-year increase in net profit in the first half of the year, and an interim dividend payout of 0.951 yuan.
HK Stock Market Move | Hansoh Pharma (03692) surged nearly 6% after its performance report. Net profit in the first half of the year increased by 15% year-on-year, with innovative drug revenue accounting for over 80%.

A-share market opening express | A-shares continue to rebound! The ChiNext Index rises over 1%, and pharmaceutical stocks are collectively strong.

HK Stock Market Move | ONEWO (02602) surged more than 13% with a 3.88% year-on-year increase in net profit in the first half of the year, and an interim dividend payout of 0.951 yuan.

RECOMMEND

Former Innovative Pharma Star Faces Growing Pains—Why Zai Lab’s Stock Tumbled Despite Strong Results
18/08/2025

World Humanoid Robot Games In-Depth: Competition Drives Technological Innovation and Accelerates Industry Progress
18/08/2025

Guangdong Cross-Border E-Commerce: Tariff Pressures Spur Overseas Warehouse Boom as Sellers Target Russia and Latin America
18/08/2025